Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes.

Kari Anne Sveen Kristine B HolteMona SvantesonKristian F HanssenJan NillsonEva BengtssonTore Julsrud Berg

Published in: Diabetes care (2021)

Autoantibodies against AGE-modified apoB100 are inversely associated with coronary atherosclerosis and proliferative retinopathy, suggesting vascular protective effects of these autoantibodies in type 1 diabetes.

Keyphrases

type diabetes
coronary artery
systemic lupus erythematosus
cardiovascular disease
pulmonary artery
glycemic control
coronary artery disease
insulin resistance
heart failure
metabolic syndrome
aortic valve
atrial fibrillation